SIBEL, Belgium's sole surgical instrument manufacturer, has been successfully acquired through a Management Buy-Out led by key management members, securing its local heritage while promising future growth.
Target Company Overview
SIBEL, the sole Belgian manufacturer of surgical instruments, has successfully completed a Management Buy-Out (MBO) led by key members of its management team. Founded by Olivier Rouvez, the company is headquartered in Gembloux and is renowned for its exceptional industrial craftsmanship, with over 90% of its production earmarked for export. SIBEL enjoys a strong international reputation, providing high-quality surgical instruments that are integral to medical procedures worldwide.
The MBO sees Marie and Rémi Bertrand, who have been integral to the company's operations, joined by their brother Tanguy as they take over the reins from Rouvez. This transition reflects not only a continuation of the family's legacy within the company but also a commitment to preserving local expertise and innovation rather than allowing the business to fall into foreign hands.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
Belgium's medical device industry is characterized by a strong emphasis on innovation and quality, positioning it as one of the leading markets in Europe. The country boasts a ro
Similar Deals
CPF Living Communities → Rivertown Ridge
2025
Three buying groups → The Joint Corp.
2025
KKA Partners → BLACKROLL
2025
Marie et Rémi Bertrand, Tanguy Bertrand
invested in
SIBEL
in 2024
in a Management Buyout / Buy-In (MBO) deal